London School of Hygiene & Tropical Medicine
Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
This is a contract result notice, not an open opportunity. Details from the official award data.
The procurement contact named on the official notice.
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign.
Recruitment period is 24 months - campaign approximately once every 6 months.
Make the case to bid
Reveal who to approach at London School of Hygiene & Tropical Medicine, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-02f911
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 024521-2023
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
London School of Hygiene & Tropical Medicine’s tender network